Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Progress toward personalized treatment of rheumatoid arthritis.

Keith MP, Edison JD, Gilliland WR.

Clin Pharmacol Ther. 2012 Oct;92(4):440-2. doi: 10.1038/clpt.2012.124. Epub 2012 Aug 22. Review.

PMID:
22910444
2.

[Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].

Taniguchi A, Urano W, Tanaka E, Kamatani N.

Nihon Rinsho. 2007 Feb;65(2):371-9. Review. Japanese.

PMID:
17302286
3.

A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.

Tak PP.

Rheumatology (Oxford). 2012 Apr;51(4):600-9. doi: 10.1093/rheumatology/ker300. Epub 2011 Sep 2.

4.

Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?

Ranganathan P, Eisen S, Yokoyama WM, McLeod HL.

Ann Rheum Dis. 2003 Jan;62(1):4-9. Review.

5.

Pharmacogenomics in rheumatoid arthritis.

Ranganathan P.

Methods Mol Biol. 2008;448:413-35. doi: 10.1007/978-1-59745-205-2_14. Review.

PMID:
18370240
6.
7.

Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.

Devine EB, Alfonso-Cristancho R, Sullivan SD.

Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39.

PMID:
21182357
8.

The need for personalised medicine for rheumatoid arthritis.

Isaacs JD, Ferraccioli G.

Ann Rheum Dis. 2011 Jan;70(1):4-7. doi: 10.1136/ard.2010.135376. Epub 2010 Nov 10.

PMID:
21068091
9.

Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

Ranganath VK, Furst DE.

Clin Geriatr Med. 2005 Aug;21(3):649-69, viii. Review.

PMID:
15911212
10.

[Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy in Poland].

Samborski W, Buczek J, Bednarek A, Lewandowicz J, Kucharz E.

Pol Merkur Lekarski. 2010 Dec;29(174):365-8. Polish.

PMID:
21298986
11.

Medical therapy: where are we now?

Resman-Targoff BH.

Am J Health Syst Pharm. 2006 Sep 15;63(18 Suppl 4):S11-8. Review.

PMID:
16960243
12.

[Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].

Zborovskiĭ AB, Sivordova LE, Derevianko LI, Zborovskaia IA, Zavodovskiĭ BV.

Ter Arkh. 1999;71(1):60-3. Russian.

PMID:
10097305
13.

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.

Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E.

Ann Rheum Dis. 2011 Feb;70(2):266-71. doi: 10.1136/ard.2010.132134. Epub 2010 Nov 19. Review. Erratum in: Ann Rheum Dis. 2011 Mar;70(3):560.

PMID:
21097801
14.

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.

Wessels JA, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF, Huizinga TW, Guchelaar HJ; Pharmacogenetics Collaborative Research Group.

Arthritis Rheum. 2007 Jun;56(6):1765-75.

15.

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.

Arch Intern Med. 1999 Nov 22;159(21):2542-50.

PMID:
10573044
16.

The role of current strategies in the future treatment of rheumatoid arthritis.

Weinblatt ME.

Rheumatology (Oxford). 1999 Nov;38 Suppl 2:19-23. Review.

PMID:
10646485
17.

A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.

Hobl EL, Mader RM, Jilma B, Duhm B, Mustak M, Bröll H, Högger P, Erlacher L.

Clin Ther. 2012 May;34(5):1195-203. doi: 10.1016/j.clinthera.2012.03.059. Epub 2012 Apr 18.

PMID:
22516039
19.

Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.

Owen SA, Lunt M, Hider SL, Bruce IN, Barton A, Thomson W.

Arthritis Rheum. 2010 Dec;62(12):3827-9. doi: 10.1002/art.27754. No abstract available.

20.

Therapeutic options for rheumatoid arthritis.

Feely MG, Erickson A, O'Dell JR.

Expert Opin Pharmacother. 2009 Sep;10(13):2095-106. doi: 10.1517/14656560903071043. Review.

PMID:
19606939

Supplemental Content

Support Center